These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2896103)

  • 1. Platypnea induced by worsening of VA/Q inhomogeneity in the sitting position in chronic obstructive lung disease.
    Michel O; Sergysels R; Ham H
    Chest; 1988 May; 93(5):1108-10. PubMed ID: 2896103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in ventilation-perfusion matching by almitrine in COPD.
    Mélot C; Naeije R; Rothschild T; Mertens P; Mols P; Hallemans R
    Chest; 1983 Mar; 83(3):528-33. PubMed ID: 6130897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of nocturnal hypoxia in chronic obstructive bronchopneumopathies].
    Weitzenblum E; Kurtz D; Krieger J; Apprill M; Kessler R
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():387-90. PubMed ID: 2902609
    [No Abstract]   [Full Text] [Related]  

  • 4. [Almitrine bismesylate and ventilation-perfusion ratios].
    Evrard Y
    Rev Mal Respir; 1985; 2 Suppl 1():S17-22. PubMed ID: 2870542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is chronic hypoxaemia and/or hypercapnia of the obstructive patient reversible? The role of almitrine bismesylate.
    Eur J Respir Dis Suppl; 1986; 146():609-718. PubMed ID: 2877898
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of oral almitrine on the distribution of VA/Q ratio in chronic obstructive lung diseases (author's transl)].
    Castaing Y; Manier G; Varène N; Guénard H
    Bull Eur Physiopathol Respir; 1981; 17(6):917-32. PubMed ID: 7032629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nocturnal hypoxemia of chronic obstructive bronchopathies and almitrine dimesylate].
    Racineux JL; Hubert P; Meslier N; Monrigal JP
    Rev Med Interne; 1985; 6 Spec No():39-42. PubMed ID: 3834559
    [No Abstract]   [Full Text] [Related]  

  • 8. Beneficial effects of almitrine bismesylate on pulmonary gas exchange in COPD.
    Melot C; Naeije R; Hallemans R; Mols P; Lejeune P
    Eur J Respir Dis Suppl; 1983; 126():249-54. PubMed ID: 6586439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of almitrine bismesylate on hypoxemia in chronic obstructive pulmonary disease.
    Bell RC; Mullins RC; West LG; Bachand RT; Johanson WG
    Ann Intern Med; 1986 Sep; 105(3):342-6. PubMed ID: 3527011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Almitrine as a long term treatment for chronic obstructive pulmonary disease.
    Kauffmann F
    Bull Eur Physiopathol Respir; 1987; 23(6):667. PubMed ID: 2899444
    [No Abstract]   [Full Text] [Related]  

  • 11. Almitrine decreases compliance of pulmonary arteries in COPD.
    Hervé P; Simonneau G; Duroux P
    Chest; 1988 Nov; 94(5):1119-20. PubMed ID: 2903012
    [No Abstract]   [Full Text] [Related]  

  • 12. VA/Q ratios distribution and oral almitrine bismesylate in COPD patients under mechanical ventilation: preliminary results.
    Castaing Y; Manier G; Guenard H
    Eur J Respir Dis Suppl; 1983; 126():243-7. PubMed ID: 6586438
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term effects of almitrine bismesylate on oxygenation during wakefulness and sleep in chronic obstructive pulmonary disease.
    Gothe B; Cherniack NS; Bachand RT; Szalkowski MB; Bianco KA
    Am J Med; 1988 Mar; 84(3 Pt 1):436-44. PubMed ID: 2894764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of long-term almitrine therapy on sleep hypoxaemia in patients with chronic airways obstruction.
    Racineux JL; Meslier N; Hubert P
    Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():183s-184s. PubMed ID: 3690029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of almitrine dimesylate on gas exchange. Preliminary results in patients with chronic obstructive bronchopneumopathies under artificial ventilation].
    Castaing Y; Manier G; Guenard H
    Presse Med; 1984 Oct; 13(34):2078-82. PubMed ID: 6149535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiopulmonary effects of a single oral dose of almitrine at rest and on exercise in patients with hypoxic chronic airflow obstruction.
    Simonneau G; Meignan M; Denjean A; Raffestin B; Harf A; Prost JF
    Chest; 1986 Feb; 89(2):174-9. PubMed ID: 2867861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The first Italian clinical experience with almitrine bismesylate].
    Grassi V; Bottino G; Blasi A; Grassi C
    Rev Mal Respir; 1985; 2 Suppl 1():S53-60. PubMed ID: 2870548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of hypoxic pulmonary vasoconstriction by almitrine in the dog.
    Romaldini H; Rodriguez-Roisin R; Wagner PD; West JB
    Am Rev Respir Dis; 1983 Aug; 128(2):288-93. PubMed ID: 6136245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in ventilation-perfusion relationships by almitrine in patients with chronic obstructive pulmonary disease during mechanical ventilation.
    Castaing Y; Manier G; Guenard H
    Am Rev Respir Dis; 1986 Nov; 134(5):910-6. PubMed ID: 3022628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of almitrine dimesylate on pulmonary hemodynamics in healthy subjects and in patients with chronic obstructive bronchitis].
    Ansquer JC
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():409-10. PubMed ID: 2902612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.